Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.42 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.41 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13651823 | 0.89 | MAPT (0.39) | MAPTALDH1A1 | |
| SCHEMBL4807529 | 0.89 | TDP1 (0.38) | TDP1MAPK1EPHX2S1PR1S1PR5 | |
| SCHEMBL13651822 | 0.89 | TDP1 (0.38) | TDP1MAPK1EPHX2S1PR1S1PR5 | |
| SCHEMBL4810156 | 0.87 | MAPT (0.38) | S1PR1KMT2AMAPTMEN1CYP2C9 | |
| SCHEMBL4806456 | 0.85 | NPC1 (0.48) | MAPK1MAPTALDH1A1SIGMAR1 | |
| SCHEMBL13651821 | 0.85 | ALDH1A1 (0.36) | MAPTTSHRALDH1A1 | |
| SCHEMBL13651779 | 0.85 | ALDH1A1 (0.49) | KMT2AMAPTMEN1TSHRALDH1A1 | |
| SCHEMBL4809265 | 0.84 | MAPT (0.35) | MAPTALDH1A1 | |
| SCHEMBL4806817 | 0.83 | MAOA (0.33) | TDP1MAPK1KMT2AMAPTMEN1 | |
| SCHEMBL14193810 | 0.82 | NPC1 (0.37) | MAPTSMN1; SMN2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090252895-A1 | Actinic ray curable composition, actinic ray curable ink and image formation method employing the ink | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2009-10-08 | — | — | US | disclosed |
| US-20090252895-A1 | Actinic ray curable composition, actinic ray curable ink and image formation method employing the ink | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2009-10-08 | — | — | US | disclosed |
| US-20080107821-A1 | Polymerizable Actinic Radiation Curable Composition, Polymerization Method, Actinic Radiation Curable Ink and Image Formation Method, and Ink Jet Recording Apparatus and Epoxy Compound | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2008-05-08 | — | — | US | disclosed |
| US-20080107821-A1 | Polymerizable Actinic Radiation Curable Composition, Polymerization Method, Actinic Radiation Curable Ink and Image Formation Method, and Ink Jet Recording Apparatus and Epoxy Compound | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2008-05-08 | — | — | US | disclosed |
| US-7360883-B2 | Active ray curable ink, image forming method and ink-jet recording apparatus | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2008-04-22 | — | — | US | disclosed |
| EP-1840148-A1 | POLYMERIZABLE ACTINIC RADIATION CURABLE COMPOSITION, POLYMERIZATION METHOD, ACTINIC RADIATION CURABLE INK AND IMAGE FORMATION METHOD, AND INK JET RECORDING APPARATUS AND EPOXY COMPOUND | Konica Minolta Medical & Graphic, Inc. (JP) | 2007-10-03 | — | — | EP | disclosed |
| US-20070219292-A1 | INK SET FOR INK-JET RECORDING, POLYMERIZATION METHOD AND IMAGE FORMING METHOD | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2007-09-20 | — | — | US | disclosed |
| US-20070219292-A1 | INK SET FOR INK-JET RECORDING, POLYMERIZATION METHOD AND IMAGE FORMING METHOD | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2007-09-20 | — | — | US | disclosed |
| EP-1829936-A1 | ACTIVE RAY-CURABLE COMPOSITION, ACTIVE RAY-CURABLE INK AND IMAGE-FORMING METHOD | Konica Minolta Medical & Graphic, Inc. (JP) | 2007-09-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080107821-A1 | Polymerizable Actinic Radiation Curable Composition, Polymerization Method, Actinic Radiation Curable Ink and Image Formation Method, and Ink Jet Recording Apparatus and Epoxy Compound | CBR3, CBR1, CNR1 | TDP1 3529/4885MAPK1 1476/4885EPHX2 185/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.